Speaker illustration

Doctor Anthony Paulo Sunjaya

University of New South Wales, Sydney (Australia)

Anthony Paulo Sunjaya is a medical doctor and currently a Scientia Doctoral Researcher at the Respiratory Division, The George Institute for Global Health, UNSW Sydney, Australia. His research focuses include respiratory disease, cardiovascular medicine, clinical trials, health informatics, health economics, health systems and primary care. He has a special interest on supporting universal health coverage and improving care in low middle income countries. He currently acts as Vice-President External Affairs, ASEAN Society UNSW and Vice-Chair Digital Transformation Leadership working group in the International Society for Telemedicine and e-Health (ISfTeH), one of two digital health associations with direct affliation to WHO. He's also a member of the e-Health Economics, Chronic Disease Management, and Medical and Bioinformatics working groups. Furthermore, he's an Editorial Fellow at the Annals of Family Medicine, University of Michigan, USA, peer reviewer for multiple interntional

Evening anti-hypertensive dosing improves blood pressure control and reduce cardiovascular events in hypertensive: a meta-analysis of 40 trials in 44,167 patients

Event: ESC Congress 2020

Topic: Pharmacotherapy

Session: Hypertension ePosters

Thumbnail

Experimental model for heart failure in rats: apelin-13/apj and bnp-45 gene expression analysis

Event: ESC Congress 2019

Topic: Biomarkers

Session: Mitochondria and lipids in the heart

Thumbnail

Characteristics and management of post-acute coronary syndrome acute heart failure patients in indonesia

Event: Heart Failure 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Acute Heart Failure – Epidemiology, Prognosis, Outcome

Thumbnail

Reduced ischemic time of acute coronary syndrome patients with indonesia telecardiology network: insights and challenges from a three year single center experience in West Jakarta

Event: Acute Cardiovascular Care 2019

Topic: e-Cardiology/Digital Health, Other

Session: Imaging - e-Cardiology

Thumbnail

Evening anti-hypertensive dosing improves blood pressure control and reduce cardiovascular events in hypertensive: a meta-analysis of 40 trials in 44,167 patients

Event: ESC Asia with APSC & AFC 2020

Topic: Pharmacotherapy

Session: Abstract Programme

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb